Viewing Study NCT00006206



Ignite Creation Date: 2024-05-05 @ 11:22 AM
Last Modification Date: 2024-10-26 @ 9:05 AM
Study NCT ID: NCT00006206
Status: COMPLETED
Last Update Posted: 2010-05-03
First Post: 2000-09-11

Brief Title: COMBINE AcamprosateNaltrexone
Sponsor: University of North Carolina Chapel Hill
Organization: University of North Carolina Chapel Hill

Study Overview

Official Title: COMBINE Effect of Combined Pharmacotherapies and Behavioral Interventions
Status: COMPLETED
Status Verified Date: 2007-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Combine is a multicenter randomized clinical trial that will evaluate combinations of three interventions for treating alcohol dependence The goal is to determine whether improvement in treatment outcomes can be achieved by various combinations of drug and behavioral interventions Two of the interventions will consist of pharmacological treatment with naltrexone Revia or acamprosate Campral The third intervention is a multicomponent behavioral therapy including such components as motivational enhancement therapy cognitive behavioral therapy and referral to self-help groups including AA All three interventions will include a component supporting compliance to medications and reduction in drinking
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
U10AA011756 NIH None httpsreporternihgovquickSearchU10AA011756
U10AA011721 NIH None None
U10AA011783 NIH None None
U10AA011715 NIH None None
U10AA011799 NIH None None
U10AA011773 NIH None None
U10AA011776 NIH None None
U10AA011777 NIH None None
U10AA011727 NIH None None
U10AA011716 NIH None None
U10AA011787 NIH None None
U10AA011768 NIH None None